Fig. 4
From: Risk-stratification in febrile infants 29 to 60 days old: a cost-effectiveness analysis
Probabilistic sensitivity analysis, PECARN vs Boston, bacteremia model. Results of the probabilistic sensitivity analysis represented as a scatterplot of the incremental cost (x-axis) and incremental effectiveness (y-axis) of the Boston strategy as compared to the PECARN strategy. The willingness-to-pay threshold of $100,000/quality-adjusted life-year, is indicated by the diagonal dashed line